Predictors of Gleason score upgrading in patients with prostate biopsy Gleason score ≤6

Authors

  • Hasmet Sarici Ankara Training and Research Hospital
  • Onur Telli Ankara Training and Research Hospital
  • Orhan Yigitbasi Ankara Yıldırım Bayezit Training and Research Hospital
  • Musa Ekici Ankara Yıldırım Bayezit Training and Research Hospital
  • Berat Cem Ozgur Ankara Training and Research Hospital
  • Cem Nedim Yuceturk Ankara Training and Research Hospital
  • Muzaffer Eroglu Ankara Training and Research Hospital

DOI:

https://doi.org/10.5489/cuaj.1499

Keywords:

Gleason score upgrading, prostatic neoplasm, prostatectomy, prostate biopsy

Abstract

Introduction: The discrepancy between prostate biopsy and prostatectomy Gleason scores is common. We investigate the predictive value of prostate biopsy features for predicting Gleason score (GS) upgrading in patients with biopsy Gleason scores ≤6 who underwent radical retropubic prostatectomy (RRP). Our aim was to determine predictors of GS upgrading and to offer guidance to clinicians in determining the therapeutic option.

Methods: We performed a retrospective study of patients who underwent RRP for clinically localized prostate cancer at 2 major centres between January 2007 and March 2013. All patients with either abnormal digital examination or elevated prostate-specific antigen at screening underwent transrectal ultrasound-guided prostate biopsy. Variables were evaluated among the patients with and without GS upgrading. Our study limitations include its retrospective design, the fact that all subjects were Turkish and the fact that we had a small sample size.

Results: In total, 321 men had GS ≤6 on prostate biopsy. Of these, 190 (59.2%) had GS ≤6 concordance and 131 (40.8%) had GS upgrading from ≤6 on biopsy to 7 or higher at the time of the prostatectomy. Independent predictors of pathological upgrading were prostate volume <40 cc (p < 0.001), maximum percent of cancer in any core (p = 0.011), and >1 core positive for cancer (p < 0.001).

Conclusions: When obtaining an extended-core biopsy scheme, patients with small prostates (≤40 cc), greater than 1 core positive for cancer, and an increased burden of cancer are associated with increased risk of GS upgrading. Patients with GS ≤6 on biopsy with these pathological parameters should be carefully counselled on treatment decisions.

Downloads

Download data is not yet available.

Author Biographies

Hasmet Sarici, Ankara Training and Research Hospital

Urology, MD

Onur Telli, Ankara Training and Research Hospital

Urology, MD

Orhan Yigitbasi, Ankara Yıldırım Bayezit Training and Research Hospital

Urology, MD

Musa Ekici, Ankara Yıldırım Bayezit Training and Research Hospital

Urology, MD

Berat Cem Ozgur, Ankara Training and Research Hospital

Urology, MD

Cem Nedim Yuceturk, Ankara Training and Research Hospital

Urology, MD

Muzaffer Eroglu, Ankara Training and Research Hospital

Urology, MD

Downloads

Published

2014-05-21

How to Cite

Sarici, H., Telli, O., Yigitbasi, O., Ekici, M., Ozgur, B. C., Yuceturk, C. N., & Eroglu, M. (2014). Predictors of Gleason score upgrading in patients with prostate biopsy Gleason score ≤6. Canadian Urological Association Journal, 8(5-6), e342–6. https://doi.org/10.5489/cuaj.1499

Issue

Section

Original Research

Similar Articles

You may also start an advanced similarity search for this article.